Cost-effectiveness of infant hypoallergenic formulas to manage cow’s milk protein allergy in France

ABSTRACTBackground Clinician’s choice of hypoallergenic formulas in the first-line management of cow’s milk protein allergy (CMPA) should be informed by evidence on clinical efficacy and cost-effectiveness.Objective We compare the cost-effectiveness of amino acid-based formula (AAF), extensively hyd...

Full description

Saved in:
Bibliographic Details
Main Authors: Ana Teresa Paquete, Rui Martins, Mark P. Connolly, Marie Meulle, Nítida Pastor, Grégoire Benoist, Patrick Tounian
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Journal of Market Access & Health Policy
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/20016689.2022.2154418
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850239055299608576
author Ana Teresa Paquete
Rui Martins
Mark P. Connolly
Marie Meulle
Nítida Pastor
Grégoire Benoist
Patrick Tounian
author_facet Ana Teresa Paquete
Rui Martins
Mark P. Connolly
Marie Meulle
Nítida Pastor
Grégoire Benoist
Patrick Tounian
author_sort Ana Teresa Paquete
collection DOAJ
description ABSTRACTBackground Clinician’s choice of hypoallergenic formulas in the first-line management of cow’s milk protein allergy (CMPA) should be informed by evidence on clinical efficacy and cost-effectiveness.Objective We compare the cost-effectiveness of amino acid-based formula (AAF), extensively hydrolyzed casein formula with Lactobacillus rhamnosus Gorbach Goldin (EHCF+LGG), extensively hydrolyzed whey formula (EHWF), and rice hydrolyzed formula (RHF) in non-breastfed children in France.Methods Immunotolerance and atopic manifestations’ prevalence were based on a prospective non-randomized study with a 36-month follow-up. Resource utilization was sourced from a survey of French clinicians, and unit costs were based on national data. Costs and health consequences were discounted at 2.5% annually. Results were reported using the Collective and French National Health Insurance perspectives.Results Children receiving EHCF+LGG were predicted to require less healthcare resources, given their reduced prevalence of CMPA symptoms at 3 years. In the base case, EHCF+LGG led to savings of at least €674 per child compared to AAF, EHWF, and RHF at 3 years, from both perspectives. Nutrition had the highest economic burden in CMPA, driven by hypoallergenic formulas and dietetic replacements costs. Results were robust to one-way and probabilistic sensitivity analyses.Conclusions EHCF+LGG was associated with more symptom-free time, higher immune tolerance, and lower costs.
format Article
id doaj-art-1a29bbb2e7da4e1abab39b5a0ce1ab4a
institution OA Journals
issn 2001-6689
language English
publishDate 2023-12-01
publisher MDPI AG
record_format Article
series Journal of Market Access & Health Policy
spelling doaj-art-1a29bbb2e7da4e1abab39b5a0ce1ab4a2025-08-20T02:01:15ZengMDPI AGJournal of Market Access & Health Policy2001-66892023-12-0111110.1080/20016689.2022.2154418Cost-effectiveness of infant hypoallergenic formulas to manage cow’s milk protein allergy in FranceAna Teresa Paquete0Rui Martins1Mark P. Connolly2Marie Meulle3Nítida Pastor4Grégoire Benoist5Patrick Tounian6Health Economics Unit, Health Economics Consultants, Global Market Access Solutions, St-Prex, SwitzerlandHealth Economics Unit, Health Economics Consultants, Global Market Access Solutions, St-Prex, SwitzerlandHealth Economics Unit, Health Economics Consultants, Global Market Access Solutions, St-Prex, SwitzerlandBenckiser Healthcare France, Reckitt Benckiser, Paris, FranceMedical and Scientific Affairs, Nutrition, Reckitt Benckiser, 47721, Evansville, IN, USADepartment of Pediatrics, CHU Ambroise Paré, APHP, 92100, Boulogne-Billancourt, FrancePediatric Nutrition and Gastroenterology Department, Trousseau hospital, APHP, Sorbonne University, Paris, FranceABSTRACTBackground Clinician’s choice of hypoallergenic formulas in the first-line management of cow’s milk protein allergy (CMPA) should be informed by evidence on clinical efficacy and cost-effectiveness.Objective We compare the cost-effectiveness of amino acid-based formula (AAF), extensively hydrolyzed casein formula with Lactobacillus rhamnosus Gorbach Goldin (EHCF+LGG), extensively hydrolyzed whey formula (EHWF), and rice hydrolyzed formula (RHF) in non-breastfed children in France.Methods Immunotolerance and atopic manifestations’ prevalence were based on a prospective non-randomized study with a 36-month follow-up. Resource utilization was sourced from a survey of French clinicians, and unit costs were based on national data. Costs and health consequences were discounted at 2.5% annually. Results were reported using the Collective and French National Health Insurance perspectives.Results Children receiving EHCF+LGG were predicted to require less healthcare resources, given their reduced prevalence of CMPA symptoms at 3 years. In the base case, EHCF+LGG led to savings of at least €674 per child compared to AAF, EHWF, and RHF at 3 years, from both perspectives. Nutrition had the highest economic burden in CMPA, driven by hypoallergenic formulas and dietetic replacements costs. Results were robust to one-way and probabilistic sensitivity analyses.Conclusions EHCF+LGG was associated with more symptom-free time, higher immune tolerance, and lower costs.https://www.tandfonline.com/doi/10.1080/20016689.2022.2154418Cow’s milk protein allergyCost-effectiveness analysischild nutrition sciencesmilk substitutesFrance
spellingShingle Ana Teresa Paquete
Rui Martins
Mark P. Connolly
Marie Meulle
Nítida Pastor
Grégoire Benoist
Patrick Tounian
Cost-effectiveness of infant hypoallergenic formulas to manage cow’s milk protein allergy in France
Journal of Market Access & Health Policy
Cow’s milk protein allergy
Cost-effectiveness analysis
child nutrition sciences
milk substitutes
France
title Cost-effectiveness of infant hypoallergenic formulas to manage cow’s milk protein allergy in France
title_full Cost-effectiveness of infant hypoallergenic formulas to manage cow’s milk protein allergy in France
title_fullStr Cost-effectiveness of infant hypoallergenic formulas to manage cow’s milk protein allergy in France
title_full_unstemmed Cost-effectiveness of infant hypoallergenic formulas to manage cow’s milk protein allergy in France
title_short Cost-effectiveness of infant hypoallergenic formulas to manage cow’s milk protein allergy in France
title_sort cost effectiveness of infant hypoallergenic formulas to manage cow s milk protein allergy in france
topic Cow’s milk protein allergy
Cost-effectiveness analysis
child nutrition sciences
milk substitutes
France
url https://www.tandfonline.com/doi/10.1080/20016689.2022.2154418
work_keys_str_mv AT anateresapaquete costeffectivenessofinfanthypoallergenicformulastomanagecowsmilkproteinallergyinfrance
AT ruimartins costeffectivenessofinfanthypoallergenicformulastomanagecowsmilkproteinallergyinfrance
AT markpconnolly costeffectivenessofinfanthypoallergenicformulastomanagecowsmilkproteinallergyinfrance
AT mariemeulle costeffectivenessofinfanthypoallergenicformulastomanagecowsmilkproteinallergyinfrance
AT nitidapastor costeffectivenessofinfanthypoallergenicformulastomanagecowsmilkproteinallergyinfrance
AT gregoirebenoist costeffectivenessofinfanthypoallergenicformulastomanagecowsmilkproteinallergyinfrance
AT patricktounian costeffectivenessofinfanthypoallergenicformulastomanagecowsmilkproteinallergyinfrance